Evidence map›Paper›PMID 31855149›Full record

ArticleBlood transfusion = Trasfusione del sangue2020

Early intravenous iron administration in the Emergency Department reduces red blood cell unit transfusion, hospitalisation, re-transfusion, length of stay and costs.

Ivo Beverina, Giancarlo Razionale, Monica Ranzini, Alessandro Aloni, Sergio Finazzi, Bruno Brando

Registry-linked trialAbstract read
In one paragraph

Article in Blood transfusion = Trasfusione del sangue, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05304442 (Intravenous Ferric Derisomaltose for Moderate to Severe Anemia Due to Uterine Bleeding in the Emergency Department), which is not on this map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05304442 phase3recruitingnot on this mapstarted 2022, after this paper: background citation

Intravenous Ferric Derisomaltose for Moderate to Severe Anemia Due to Uterine Bleeding in the Emergency Department: a Randomized Trial

TypeinterventionalSponsorBaylor College of MedicineRan2022 to 2025Enrolled40ConditionsAnemia, Iron Deficiency, Uterine BleedingArmsFerric Derisomaltose 1000 Mg in 10 mL INTRAVENOUS SOLUTION [Monoferric], Ferrous Sulfate 65 mg elemental iron (325 mg tablets)
3 · Its place in the literature

Who cites it

18 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Cost Reduction in Blood Transfusions After Implementation of Decision Protocol Based on Hemoglobin and Anemia Symptoms: A Pre-Post Analysis.Medical science monitor : international medical journal of experimental and clinical research · 2024
    Article
  5. Article
  6. Article
  7. Article
  8. Intravenous iron therapy in pediatrics: who should get it and when is the right time?Hematology. American Society of Hematology. Education Program · 2023
    Article
  9. [Iron in pre-operative stage and transfusion in patients undergoing hysterectomy].Revista medica del Instituto Mexicano del Seguro Social · 2023
    Article
  10. Article
  11. Iron, iron everywhere and not a transfusion should be had.Blood transfusion = Trasfusione del sangue · 2023
    Article
  12. Article
  13. Article
  14. Observational
  15. Article
  16. A nationwide survey of clinical use of blood in Italy.Blood transfusion = Trasfusione del sangue · 2021
    Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Ivo BeverinaBlood Transfusion Centre, Legnano General Hospital, Legnano, Italy.
Giancarlo RazionaleEmergency Department, Legnano General Hospital, Legnano, Italy.
Monica RanziniEmergency Department, Legnano General Hospital, Legnano, Italy.
Alessandro AloniBlood Transfusion Centre, Legnano General Hospital, Legnano, Italy.
Sergio FinazziClinical Chemistry Laboratory, Legnano General Hospital, Legnano, Italy.
Bruno BrandoBlood Transfusion Centre, Legnano General Hospital, Legnano, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundModerate to severe iron deficiency anaemia is a common finding in patients admitted to the Emergency Department (ED). According to Patient Blood Management principles, intravenous iron should be the therapy of choice instead of blood transfusion for selected cases affected by chronic iron deficiency anaemia. However, this option is only rarely taken into account by physicians in the ED. As a result, in many circumstances, treatment of iron deficiency anaemia in the ED can differ from that of the Anaemia Clinic. With the aim of reducing inappropriate transfusions, and to implement intravenous iron usage, we shared a specific protocol with the ED. MATERIAL AND

methodsWe reviewed the medical records of all subjects admitted to the ED (n=267, Post-protocol group) with hemoglobin ≤9.0 g/dL and mean corpuscular volume <80 fL in a 13-month period, except if the massive transfusion protocol was activated, and results were compared with an equivalent Pre-protocol historical cohort (n=226).

resultsIn comparison with the Pre-protocol series, the number of patients transfused did not change, but the appropriateness in terms of transfusion and red blood cell volume transfused improved sharply (87.0 vs 13.3%; p<0.001) with a significant increase in intravenous iron administration (50.2 vs 4.4% of cases; p<0.001). As a positive consequence, both the time spent in the ED by patients who were then directly discharged and costs per subject treated dropped by 37.9% and 59.0%, respectively. Treatment with infusion only in comparison with transfusion only led to a statistically significant Relative Risk reduction in transfusion on the ward and post-discharge transfusion of 55.6% and 44.4%, respectively. DISCUSSION: The implementation of Patient Blood Management principles and early intravenous iron therapy in the Emergency Department have proved to be effective tools to optimise resources both in terms of units transfused and costs.

Indexed as

Erythrocyte TransfusionAdministration, IntravenousAgedAged, 80 and overAnemia, Iron-DeficiencyCosts and Cost AnalysisEmergency Medical ServicesEmergency Service, HospitalFemaleHealth Care CostsHospitalizationHumansIronLength of StayMaleIron

Identifiers

PMID31855149
PMCPMC7141934

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.